BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2010
View Archived Issues
Aphios receives phase I of fast track SBIR grant for new nanodrug for AD
Read More
FDA advisory committee votes on sNDA for Avodart in prostate cancer
Read More
New GABA(A) alpha5 receptor ligands discovered at Roche
Read More
Phase I/II data presented on MLN-8237 in hematological malignancies
Read More
BI-6727 shows promise in phase I/II trial in acute myeloid leukemia
Read More
Bivalent oral poliovirus vaccine bOPV is superior to trivalent vaccine in Indian newborns
Read More
ACT Biotech describes unique mechanism of action of ACTB-1003
Read More
ArQule begins phase I trial of ARQ-736 in advanced solid tumors
Read More
LFB Biotechnologies completes acquisition of GTC Biotherapeutics
Read More
Gruenenthal presents new TRPV1 channel ligands
Read More
First European approval granted for Sumavel DosePro for migraine
Read More
Merck & Co. describes new somatostatin sst5 receptor antagonists
Read More
Sangart and U.S. navy join to develop MP4 to treat traumatic brain injury
Read More
Pharmaxis commences phase II trial of ASM-8 in asthma
Read More
Argos Therapeutics advances phase Ia trial of AGS-009 in SLE
Read More
Lilly divulges new vinyl indazolyl agents with antitumor activity
Read More
Medivation completes enrollment in phase III trial of Dimebon in Alzheimer's disease
Read More
New inhibitors of MAPK 14 identified by Merck & Co.
Read More
ArQule evaluates ARQ-087 in models of cancer
Read More
Neuraltus reports phase II data for NP-002 in levodopa-induced dyskinesias
Read More
RG-16781 improves negative symptoms of schizophrenia
Read More
Biogen and Swedish Orphan Biovitrum begin phase II/III rFVIIIFc trial
Read More
Expansion of phase IIa study of GeoVax's HIV/AIDS vaccine
Read More
PAION presents preclinical data on Solulin in hemophilia
Read More
Theratechnologies and sanofi-aventis enter agreement for Egrifta
Read More